Today on Pharmaceutical Processing
Festo to show off latest automated liquid and gas handling technology at Interphex
Esslingen, Germany–based Festo will display a range of new products at Interphex 2021, the biotech and pharma technology event scheduled for October 19 to 21 at the Javits Center in New York City. Included in the lineup will be its new VEAB pressure controller and the VEMD mass flow controller. In addition, other new products on display will include the VYKA high speed,…
Outsourcing single-use technologies to accelerate speed to market
To fast-track the time to market and gain a competitive edge, pharmaceutical development companies are increasingly implementing single-use technologies (SUT). Single-use technologies are built using an array of components, including sampling bottles, filters, Luer locks, seals and dispensing tips. The technology can be as simple as a single assembly. Or it can be an entire…
Sponsored Content See More >
Noble expands its services for its clients into Human FactorsHuman Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug…
Regulatory See More >
Novo Nordisk settles U.S. securities class action suit
Novo Nordisk (NYSE:NVO) has agreed in principle to settle securities class action litigation in the Federal District Court of New Jersey. The Bagsværd, Denmark–based company would pay $100 million in the settlement. That amount includes plaintiffs’ attorneys’ fees, expenses and settlement costs. The lawsuit alleged that the company made misleading statements regarding the price of its…
Facility See More >
Moderna to build mRNA plant in Africa
As the pendulum of vaccinating the world against COVID-19 begins to swing to developing countries, Moderna (NSDQ:MRNA) will build an mRNA facility in Africa that could produce as many as 500 million 50-µg vaccine doses annually. Its currently authorized booster has a 100-µg dose of mRNA, but the company aims to use a 50-µg dose…
Supply Chain See More >
How direct-to-patient can impact pharma supply chains
In the wake of COVID-19, telemedicine has become the only means for delivering patient care for many physician groups. As healthcare providers adapted to treating patients virtually, patients likewise adapted to disrupted routines. For those dependent on prescription medication to treat or manage a medical condition, “going to the pharmacy” was an errand replaced by…
Recalls See More >
Gilead identifies counterfeit versions of two of its HIV drugs
Gilead Sciences (NSDQ: GILD) has announced that it has identified tampered and counterfeit versions of its HIV drugs Biktarvy and Descovy in the U.S. supply chain. Biktarvy is a blockbuster drug cocktail, raking up $7.26 billion in sales last year. 2020 sales of Descovy were $478 million. Foster City, Calif.–based Gilead said that unauthorized distributors…
